Quarterly ResultJul 28, 2026, 07:07 AM
Alkermes Q2 Revenue $496.0M; GAAP Net Income $0.5M; CEO Transition
AI Summary
Alkermes plc reported Q2 2026 total revenues of $496.0 million, a significant increase from $390.7 million in Q2 2025. GAAP net income for the quarter was $0.5 million, down from $87.1 million in the prior year, while Adjusted EBITDA rose to $139.2 million. The company updated its 2026 financial expectations, widening its projected GAAP net loss to between $(95) million and $(115) million, but maintained its Adjusted EBITDA guidance. Additionally, Blair Jackson will assume the CEO role on August 1, 2026, with Richard Pops continuing as Chairman.
Key Highlights
- Blair Jackson to assume CEO role on August 1, 2026; Richard Pops to continue as Chairman.
- Q2 2026 Total Revenues increased to $496.0 million from $390.7 million year-over-year.
- Q2 2026 GAAP Net Income was $0.5 million, down from $87.1 million in Q2 2025.
- Q2 2026 Adjusted EBITDA increased to $139.2 million from $126.5 million year-over-year.
- Updated 2026 GAAP Net Loss guidance widened to $(95) million - $(115) million.
- 2026 Adjusted EBITDA guidance maintained at $370 million - $410 million.
- Proprietary net sales: VIVITROL $124.5M, ARISTADA $96.7M, LYBALVI $94.0M, LUMRYZ $96.6M.
- Cash, cash equivalents, and total investments were $691.6 million as of June 30, 2026.
Price Impact
More from ALKS